Terms: = Brain cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
181 results:
1. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
[TBL] [Abstract] [Full Text] [Related]
2. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
[No Abstract] [Full Text] [Related]
3. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D
Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802
[TBL] [Abstract] [Full Text] [Related]
4. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
[TBL] [Abstract] [Full Text] [Related]
5. CD73 mitigates ZEB1 expression in papillary thyroid carcinoma.
Vedovatto S; Oliveira FD; Pereira LC; Scheffel TB; Beckenkamp LR; Bertoni APS; Wink MR; Lenz G
Cell Commun Signal; 2024 Feb; 22(1):145. PubMed ID: 38388432
[TBL] [Abstract] [Full Text] [Related]
6. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract] [Full Text] [Related]
7. Aberrant
Al-Ghabkari A; Huang B; Park M
Cells; 2024 Jan; 13(3):. PubMed ID: 38334610
[TBL] [Abstract] [Full Text] [Related]
8. Identification of emt-associated prognostic features among grade II/III gliomas.
Yang W; Lin L; Lu T; Yu H; Zhang S
Sci Rep; 2024 Feb; 14(1):2822. PubMed ID: 38307919
[TBL] [Abstract] [Full Text] [Related]
9. EMP3 as a prognostic biomarker correlates with emt in GBM.
Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
[TBL] [Abstract] [Full Text] [Related]
10. OTX1 regulates tumorigenesis and metastasis in glioma.
Cao B; Liu K; Tian C; He H; He S; Chen H; Zhang X; Liu Y; Wang L; Liu X; Li M; Jia Q; Chai J
Pathol Res Pract; 2024 Feb; 254():155116. PubMed ID: 38218040
[TBL] [Abstract] [Full Text] [Related]
11. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
[No Abstract] [Full Text] [Related]
12. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and emt by activating STAT3 phosphorylation.
Zhang J; Li R; Zhang H; Wang S; Zhao Y
Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
[TBL] [Abstract] [Full Text] [Related]
13. Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation.
Hou W; Cai J; Shen P; Zhang S; Xiao S; You P; Tong Y; Li K; Qi Z; Luo H
Cancer Med; 2023 Dec; 12(24):22170-22184. PubMed ID: 38093622
[TBL] [Abstract] [Full Text] [Related]
14. Role of UBE2C in brain cancer Invasion and Dissemination.
Domentean S; Paisana E; Cascão R; Faria CC
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958776
[TBL] [Abstract] [Full Text] [Related]
15. ADAMTS8 inhibits glioma development in vitro and in vivo.
Zhou B; Liu Y; Ma G; Wang X; Chang B; Lu H; Feng X
Folia Neuropathol; 2023; 61(2):144-152. PubMed ID: 37587889
[TBL] [Abstract] [Full Text] [Related]
16. Dihydroartemisinin inhibits emt of glioma via gene BASP1 in extrachromosomal DNA.
Que Z; Zhou Z; Liu S; Zheng W; Lei B
Biochem Biophys Res Commun; 2023 Oct; 675():130-138. PubMed ID: 37473527
[TBL] [Abstract] [Full Text] [Related]
17. Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer.
Le Hars M; Castro-Vega LJ; Rajabi F; Tabatadze D; Romero M; Pinskaya M; Groisman I
Biol Direct; 2023 Jul; 18(1):38. PubMed ID: 37434219
[TBL] [Abstract] [Full Text] [Related]
18. Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations.
Hashemi M; Gholami S; Raesi R; Sarhangi S; Mahmoodieh B; Koohpar ZK; Goharrizi MASB; Behroozaghdam M; Entezari M; Salimimoghadam S; Zha W; Rashidi M; Abdi S; Taheriazam A; Nabavi N
Cell Signal; 2023 Sep; 109():110786. PubMed ID: 37380085
[TBL] [Abstract] [Full Text] [Related]
19. USP18 regulates the malignant phenotypes of glioblastoma stem cells.
Li L; Yin Y; Zhang J; Wu X; Liu J; Chai J; Yang Y; Li M; Jia Q; Liu Y
Pathol Res Pract; 2023 Jul; 247():154572. PubMed ID: 37257245
[TBL] [Abstract] [Full Text] [Related]
20. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
Ye L; Tong S; Wang Y; Wang Y; Ma W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
[TBL] [Abstract] [Full Text] [Related]
[Next]
